Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBT versus bupropion versus no treatment for sexual anxiety
IRCT20190122042461N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of bupropion in Sexual performance anxiety (SPA) (3 arms), sponsored by Islamic Azad University. Primary endpoint: Decrease in sexual anxiety. Started Apr 2018; status: completed.
02
Drugs
bupropion
03
Conditions
Sexual performance anxiety (SPA)
Beyond the preview
Go deeper on IRCT20190122042461N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190122042461N1.